4540 — Tsumura & Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapContrarian

Annual income statement for Tsumura & Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	116,413	129,546	140,043	150,845	181,093
Cost of Revenue
Gross Profit	60,464	66,465	68,281	68,817	90,584
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	97,444	107,627	119,561	131,045	141,101
Operating Profit	18,969	21,919	20,482	19,800	39,992
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	20,456	25,563	23,018	23,736	45,559
Provision for Income Taxes
Net Income After Taxes	14,741	19,396	17,386	18,047	34,524
Minority Interest
Net Income Before Extraordinary Items
Net Income	15,332	18,837	16,482	16,708	32,429
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15,332	18,836	16,482	16,707	32,428
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	210	257	227	229	436
Dividends per Share